Trimethoprim-sulfamethoxazole in brucellosis.
D000284:Administration, Oral; D001170:Arthritis, Infectious / Q000188:drug therapy*; D002006:Brucellosis / Q000188:drug therapy*; D004338:Drug Combinations; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D004823:Epididymitis / Q000188:drug therapy*; D005500:Follow-Up Studies; D006115:Greece; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D009920:Orchitis / Q000188:drug therapy*; D010003:Osteoarthritis / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014295:Trimethoprim / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole